{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:19:54Z","timestamp":1793063994856,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"SEMERGEN Fundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The management in primary care (PC) of the patients with Heart Failure (HF) is different from the management hospital, in a special way compared to cardiology departments.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To define the characteristics in both phenotypes of HF in prevalent and incident cases of HF in patients recruited in a large PC sample.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We proposed a and longitudinal analyses, in patients of the IBERICAN cohort, that recruited 8,066 patients in the Spanish primary care system, with 15,488 patients-years of follow-up. Of them, 252 patients (3.1%) had diagnoses of HF. HF was classified according to the 2014 guidelines in two groups: HF with a reduced eject fraction or HFrEF (LVEF\u2009&lt;\u200950%) and HF with preserved eject fraction or HFpEF (LVEF\u2009\u2265\u200950%). Recommended treatment was defined as the patient receiving drug treatment with Renin-Angiotensin-System (RAS) blockers with beta-blockers and, optionally, spironolactone. The incidence of new cases of HF was calculated in the 7,814 patients without HF in the inclusion visit. Finally, we analysed which variables associated the onset new cases and get the hazard ratio (HR) with the confidence interval at 95% ([95%CI]). Clinical trials register: NCT02261441 (02\/05\/2017).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The HFpEF was the most frequent phenotype in prevalent cases (61.1%) and incident cases (73.9%). Patients with HFrEF had a higher prevalence of coronary heart disease (<jats:italic>p<\/jats:italic>\u2009=\u20090.008) and PAD (<jats:italic>p<\/jats:italic>\u2009=\u20090.028), and no statistically significant differences was observed in the therapeutic groups used between both groups. The incidence of HF was 12.8 cases\/1000 inhabitants\/year, 35.6% of them was diagnosed in PC. The renin-angiotensin system blockers were more used in PC (60%) and beta-blockers (100%) and spironolactone (60%) in hospital. The female sex showed a protective effect for incident cases (0.51 [0.28\u20130.92]); and AF (HR [95%CI]: 2.90 [1.51\u20135.54]), coronary heart disease (HR [95%CI]: 2.18 [1.19-4.00]) and hypertension (HR [95%CI]: 1.91 [1.00-3.64]) increased the risk of developing HF.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>HF phenotype more frequent and incident in PC was the HFpEF, but only one third of them are diagnosed in PC level. The female sex showed a protective effect and atrial fibrillation, ischaemic heart disease and hypertension increased the risk of develop HF.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12875-024-02506-1","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T10:02:52Z","timestamp":1721901772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characteristics of the phenotypes in prevalent and incident cases of heart failure in primary care: IBERICAN study"],"prefix":"10.1186","volume":"25","author":[{"given":"Sergio","family":"Cinza-Sanjurjo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Prieto-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Pallar\u00e9s-Carratal\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael M.","family":"Mic\u00f3-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonsoles","family":"Velilla-Zancada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Barquilla-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leovigildo","family":"Ginel-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Segura-Fragoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Mart\u00edn-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Polo-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"2506_CR1","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.4103\/jfmpc.jfmpc_514_21","volume":"10","author":"M Seyed-Nezhad","year":"2021","unstructured":"Seyed-Nezhad M, Ahmadi B, Akbari-Sari A. Factors affecting the successful implementation of the referral system: a scoping review. J Family Med Prim Care. 2021;10:4364.","journal-title":"J Family Med Prim Care"},{"key":"2506_CR2","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","volume":"285","author":"PA McKee","year":"1971","unstructured":"McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham Study. N Engl J Med. 1971;285:1441\u20136.","journal-title":"N Engl J Med"},{"key":"2506_CR3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jacc.2021.10.043","volume":"79","author":"RS Vasan","year":"2022","unstructured":"Vasan RS, Enserro DM, Beiser AS, Xanthakis V. Lifetime risk of heart failure among participants in the Framingham Study. J Am Coll Cardiol. 2022;79:250\u201363.","journal-title":"J Am Coll Cardiol"},{"key":"2506_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcmg.2017.08.007","volume":"11","author":"RS Vasan","year":"2018","unstructured":"Vasan RS, Xanthakis V, Lyass A, Andersson C, Tsao C, Cheng S, et al. Epidemiology of left ventricular systolic dysfunction and heart failure in the Framingham Study. JACC Cardiovasc Imaging. 2018;11:1\u201311.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2506_CR5","doi-asserted-by":"crossref","unstructured":"Goyal P, Loop M, Chen L, Brown TM, Durant RW, Safford MM et al. Causes and temporal patterns of 30-Day readmission among older adults hospitalized with heart failure with preserved or reduced ejection fraction. J Am Heart Assoc. 2018;7.","DOI":"10.1161\/JAHA.117.007785"},{"key":"2506_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2408","author":"A Kap\u0142on-Cie\u015blicka","year":"2021","unstructured":"Kap\u0142on-Cie\u015blicka A, Benson L, Chioncel O, Crespo-Leiro MG, Coats AJS, Anker SD, et al. A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction \u2013 insights from the ESC-HFA EORP heart failure Long-Term Registry. Eur J Heart Fail. 2021. https:\/\/doi.org\/10.1002\/ejhf.2408.","journal-title":"Eur J Heart Fail"},{"key":"2506_CR7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jchf.2018.03.006","volume":"6","author":"CW Tsao","year":"2018","unstructured":"Tsao CW, Lyass A, Enserro D, Larson MG, Ho JE, Kizer JR, et al. Temporal trends in the incidence of and Mortality Associated with Heart failure with preserved and reduced ejection fraction. JACC Heart Fail. 2018;6:678\u201385.","journal-title":"JACC Heart Fail"},{"key":"2506_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0014-2565(07)73402-1","volume":"207","author":"GC Rodr\u00edguez Roca","year":"2007","unstructured":"Rodr\u00edguez Roca GC, Barrios Alonso V, Aznar Costa J, Llisterri Caro JL, Alonso Moreno J, Escobar Cervantes F. Caracter\u00edsticas cl\u00ednicas De Los pacientes diagnosticados de insuficiencia card\u00edaca cr\u00f3nica asistidos en Atenci\u00f3n primaria. Estudio CARDIOPRES. Rev Clin Esp. 2007;207:337\u201340.","journal-title":"Rev Clin Esp"},{"key":"2506_CR9","first-page":"611","volume":"61","author":"JR Gonz\u00e1lez-Juanatey","year":"2008","unstructured":"Gonz\u00e1lez-Juanatey JR, Ezquerra EA, Mart\u00ednez VB, Guti\u00e9rrez PC, de Santiago Nocito A, Fradera IZ. Heart failure in outpatients: comorbidities and management by different specialists. The EPISERVE Study. Revista Espa\u00f1ola De Cardiolog\u00eda. (English Edition). 2008;61:611\u20139.","journal-title":"(English Edition)"},{"key":"2506_CR10","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599\u2013726.","journal-title":"Eur Heart J"},{"key":"2506_CR11","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jamda.2020.09.019","volume":"22","author":"Y Li","year":"2021","unstructured":"Li Y, Fu MR, Luo B, Li M, Zheng H, Fang J. The effectiveness of Transitional Care Interventions on Health Care Utilization in patients discharged from the Hospital with Heart failure: a systematic review and Meta-analysis. J Am Med Dir Assoc. 2021;22:621\u20139.","journal-title":"J Am Med Dir Assoc"},{"key":"2506_CR12","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.3390\/jcm10184036","volume":"10","author":"JL Llisterri-Caro","year":"2021","unstructured":"Llisterri-Caro JL, Cinza-Sanjurjo S, Mart\u00edn-S\u00e1nchez V, Rodr\u00edguez-Roca GC, Mic\u00f3-P\u00e9rez RM, Segura-Fragoso A, et al. Prevalence of Chronic Heart failure, Associated Factors, and Therapeutic Management in Primary Care patients in Spain, IBERICAN Study. J Clin Med. 2021;10:4036.","journal-title":"J Clin Med"},{"key":"2506_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semerg.2019.10.006","volume":"46","author":"S Cinza Sanjurjo","year":"2020","unstructured":"Cinza Sanjurjo S, Llisterri Caro JL, Barquilla Garc\u00eda A, Polo Garc\u00eda J, Velilla Zancada S, Rodr\u00edguez Roca GC, et al. Descripci\u00f3n De La Muestra, dise\u00f1o y m\u00e9todos del estudio para la identificaci\u00f3n de la poblaci\u00f3n espa\u00f1ola de riesgo cardiovascular y renal (IBERICAN). Med De Familia SEMERGEN. 2020;46:4\u201315.","journal-title":"Med De Familia SEMERGEN"},{"key":"2506_CR14","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJV McMurray","year":"2012","unstructured":"McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the diagnosis and treatment of Acute and Chronic Heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787\u2013847.","journal-title":"Eur Heart J"},{"key":"2506_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S1388-9842(02)00034-X","volume":"4","author":"F Ceia","year":"2002","unstructured":"Ceia F, Fonseca C, Mota T, Morais H, Matias F, de Sousa A, et al. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur J Heart Fail. 2002;4:531\u20139.","journal-title":"Eur J Heart Fail"},{"key":"2506_CR16","first-page":"89","volume":"25","author":"G Piccoliori","year":"2017","unstructured":"Piccoliori G, Wiedermann CJ, Engl A, Sessa E, Abholz H-H. Prevalence of Chronic Heart failure in a General Practice Study Performed in the Autonomous Province of Bolzano, Italy. Qual Prim Care. 2017;25:89\u201393.","journal-title":"Qual Prim Care"},{"key":"2506_CR17","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1017\/S1463423618000889","volume":"20","author":"L Bosch","year":"2019","unstructured":"Bosch L, Assmann P, de Grauw WJC, Schalk BWM, Biermans MCJ. Heart failure in primary care: prevalence related to age and comorbidity. Prim Health Care Res Dev. 2019;20:e79.","journal-title":"Prim Health Care Res Dev"},{"key":"2506_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1858","author":"A Groenewegen","year":"2020","unstructured":"Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020. https:\/\/doi.org\/10.1002\/ejhf.1858.","journal-title":"Eur J Heart Fail"},{"key":"2506_CR19","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/ejhf.813","volume":"19","author":"O Chioncel","year":"2017","unstructured":"Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola V-P, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart failure Long-Term Registry. Eur J Heart Fail. 2017;19:1574\u201385.","journal-title":"Eur J Heart Fail"},{"key":"2506_CR20","doi-asserted-by":"publisher","first-page":"334","DOI":"10.2174\/157340309789317814","volume":"5","author":"JC Castillo","year":"2009","unstructured":"Castillo JC, Anguita MP, Jimenez M. Outcome of Heart failure with preserved ejection fraction: a Multicentre Spanish Registry. Curr Cardiol Rev. 2009;5:334\u201342.","journal-title":"Curr Cardiol Rev"},{"key":"2506_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.aprim.2010.03.021","volume":"43","author":"G Galindo Ortego","year":"2011","unstructured":"Galindo Ortego G, Esteve IC, Gatius JR, Santiago LG, Lacruz CM, Soler PS. Pacientes con El diagn\u00f3stico de insuficiencia cardiaca en Atenci\u00f3n primaria: envejecimiento, comorbilidad y polifarmacia. Aten Primaria. 2011;43:61\u20137.","journal-title":"Aten Primaria"},{"key":"2506_CR22","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.aprim.2008.10.022","volume":"41","author":"B de Rivas Otero","year":"2009","unstructured":"de Rivas Otero B, Permanyer-Miralda G, Brotons Cuixart C, Aznar Costa J, Sobreviela Bl\u00e1zquez E. Perfil cl\u00ednico Y patrones de manejo en Los pacientes con insuficiencia card\u00edaca atendidos ambulatoriamente en Espa\u00f1a: estudio INCA (Estudio Insuficiencia Card\u00edaca). Aten Primaria. 2009;41:394\u2013401.","journal-title":"Aten Primaria"},{"key":"2506_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.recesp.2020.09.014","volume":"75","author":"A Sicras-Mainar","year":"2022","unstructured":"Sicras-Mainar A, Sicras-Navarro A, Palacios B, Varela L, Delgado JF. Epidemiolog\u00eda Y tratamiento de la insuficiencia cardiaca en Espa\u00f1a: estudio PATHWAYS-HF. Rev Esp Cardiol. 2022;75:31\u20138.","journal-title":"Rev Esp Cardiol"},{"key":"2506_CR24","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","volume":"391","author":"N Conrad","year":"2018","unstructured":"Conrad N, Judge A, Tran J, Mohseni H, Hedgecott D, Crespillo AP, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet. 2018;391:572\u201380.","journal-title":"Lancet"},{"key":"2506_CR25","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1002\/ehf2.12773","volume":"7","author":"KM \u00d8degaard","year":"2020","unstructured":"\u00d8degaard KM, Hall\u00e9n J, Lirhus SS, Melberg HO, Halvorsen S. Incidence, prevalence, and mortality of heart failure: a nationwide registry study from 2013 to 2016. ESC Heart Fail. 2020;7:1917\u201326.","journal-title":"ESC Heart Fail"},{"key":"2506_CR26","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1093\/eurheartj\/ehy626","volume":"39","author":"B Zafrir","year":"2018","unstructured":"Zafrir B, Lund LH, Laroche C, Ruschitzka F, Crespo-Leiro MG, Coats AJS, et al. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry. Eur Heart J. 2018;39:4277\u201384.","journal-title":"Eur Heart J"},{"key":"2506_CR27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jchf.2020.09.006","volume":"9","author":"M Khayyat-Kholghi","year":"2021","unstructured":"Khayyat-Kholghi M, Oparil S, Davis BR, Tereshchenko LG. Worsening kidney function is the major mechanism of Heart failure in hypertension. JACC Heart Fail. 2021;9:100\u201311.","journal-title":"JACC Heart Fail"},{"key":"2506_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ejhf.1645","volume":"22","author":"M Lain\u0161cak","year":"2020","unstructured":"Lain\u0161cak M, Milinkovic I, Polovina M, Crespo-Leiro MG, Lund LH, Anker S, et al. Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart failure Long-Term Registry. Eur J Heart Fail. 2020;22:92\u2013102.","journal-title":"Eur J Heart Fail"},{"key":"2506_CR29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/ehf2.13105","volume":"8","author":"Y Rachamin","year":"2021","unstructured":"Rachamin Y, Meier R, Rosemann T, Flammer AJ, Chmiel C. Heart failure epidemiology and treatment in primary care: a retrospective cross-sectional study. ESC Heart Fail. 2021;8:489\u201397.","journal-title":"ESC Heart Fail"},{"key":"2506_CR30","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;:1\u2013128."},{"key":"2506_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejim.2018.11.001","volume":"61","author":"B \u00d6zlek","year":"2019","unstructured":"\u00d6zlek B, \u00d6zlek E, A\u011fu\u015f HZ, Tekinalp M, Kahraman S, \u00c7il C, et al. Patients with HFpEF and HFmrEF have different clinical characteristics in Turkey: a multicenter observational study. Eur J Intern Med. 2019;61:88\u201395.","journal-title":"Eur J Intern Med"},{"key":"2506_CR32","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/ejhf.1091","volume":"20","author":"V Bhambhani","year":"2018","unstructured":"Bhambhani V, Kizer JR, Lima JAC, van der Harst P, Bahrami H, Nayor M, et al. Predictors and outcomes of heart failure with mid-range ejection fraction. Eur J Heart Fail. 2018;20:651\u20139.","journal-title":"Eur J Heart Fail"}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-024-02506-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-024-02506-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-024-02506-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T10:03:23Z","timestamp":1721901803000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-024-02506-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2506"],"URL":"https:\/\/doi.org\/10.1186\/s12875-024-02506-1","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"assertion":[{"value":"23 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All patients signed the informed consent (or their legal guardians, if apply), when invited to be included in the health system through their personalized identification system (PIS). The information obtained was treated with absolute confidentiality, respecting the principles of the Declaration of Helsinki. Participants\u2019 EHR data was anonymized upon extraction. This study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Commitee of Hospital Cl\u00ednico San Carlos in Madrid on February 21, 2013 (C.P. IBERICAN- C.I. 13\/047-E) and is registered in  with the number NCT02261441.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"271"}}